Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,542 | 61,761 | 29,785 | 24,427 | 14,949 |
| Marketable Securities | 16,784 | N/A | 17,960 | 0 | 18,576 |
| Receivables | 11,601 | 1,197 | 1,631 | 3,026 | 15,402 |
| Inventories | 1,656 | N/A | N/A | N/A | N/A |
| Other current assets | 1,181 | 355 | 589 | 126 | 1,027 |
| TOTAL | $104,736 | $65,508 | $50,600 | $27,935 | $50,183 |
| Non-Current Assets | |||||
| PPE Net | 276 | 343 | N/A | N/A | N/A |
| Other Non-Current Assets | 329 | 1,061 | 0 | 0 | 15 |
| TOTAL | $605 | $1,404 | $N/A | $N/A | $15 |
| Total Assets | $105,341 | $66,912 | $50,600 | $27,935 | $50,198 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,712 | 3,380 | 1,466 | 3,499 | 2,436 |
| Accrued Expenses | 15,430 | 9,013 | 8,016 | 8,952 | 10,779 |
| Other current liabilities | N/A | 1,153 | 93 | 754 | 18,514 |
| TOTAL | $18,731 | $16,945 | $21,118 | $18,117 | $32,124 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,960 | 12,716 | 6,197 | 15,779 | 18,477 |
| Deferred Revenues | 578 | 1,974 | 1,974 | 1,658 | 395 |
| Other Non-Current Liabilities | 2,780 | 1,379 | 5,887 | 17,464 | 39,058 |
| TOTAL | $40,740 | $14,673 | $14,636 | $37,045 | $58,837 |
| Total Liabilities | $59,471 | $31,618 | $35,754 | $55,162 | $90,961 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,475 | 27,130 | 16,081 | 13,900 | 11,887 |
| Common Shares | 34 | 27 | 16 | 126 | 118 |
| Retained earnings | -674,547 | -621,205 | -585,621 | -595,009 | -586,969 |
| Other shareholders' equity | -3 | 0 | 0 | 1 | -4 |
| TOTAL | $45,870 | $35,294 | $14,846 | $-27,227 | $-40,763 |
| Total Liabilities And Equity | $105,341 | $66,912 | $50,600 | $27,935 | $50,198 |